Eine Auswahl an Publikationen von Prof. Dr. med. / Dr. rer. nat. Thomas Schneider

Wetzstein N, Fenollar F, Buffet S, Moos V, Schneider T, Raoult D
Tropheryma whipplei genotypes 1 and 3, Central Europe.
Emerg Infect Dis 2013; 19(2):341-2.
Feurle GE, Moos V, Bläker H, Loddenkemper C, Moter A, Stroux A, Marth T, Schneider T
Intravenous ceftriaxone, followed by 12 or three months of oral treatment with trimethoprim-sulfamethoxazole in Whipple's disease.
J Infect 2013; 66(3):263-70.
Moos V, Schneider T
The role of T cells in the pathogenesis of classical Whipple's disease.
Expert Rev Anti Infect Ther 2012; 10(3):253-5.
Feurle GE, Moos V, Schneider T, Fenollar F, Raoult D
The combination of chloroquine and minocycline, a therapeutic option in cerebrospinal infection of Whipple's disease refractory to treatment with ceftriaxone, meropenem and co-trimoxazole.
J Antimicrob Chemother 2012; 67(5):1295-6.
Beigier-Bompadre M, Moos V, Belogolova E, Allers K, Schneider T, Churin Y, Ignatius R, Meyer TF, Aebischer T
Modulation of the CD4+ T-cell response by Helicobacter pylori depends on known virulence factors and bacterial cholesterol and cholesterol α-glucoside content.
J Infect Dis 2011; 204(9):1339-48.
Allers K, Hütter G, Hofmann J, Loddenkemper C, Rieger K, Thiel E, Schneider T
Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation.
Blood 2011; 117(10):2791-9.
Hütter G, Nowak D, Mossner M, Ganepola S, Müssig A, Allers K, Schneider T, Hofmann J, Kücherer C, Blau O, Blau IW, Hofmann WK, Thiel E
Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.
N Engl J Med 2009; 360(7):692-8.
Schneider T, Moos V, Loddenkemper C, Marth T, Fenollar F, Raoult D
Whipple's disease: new aspects of pathogenesis and treatment.
Lancet Infect Dis 2008; 8(3):179-90.
Epple HJ, Loddenkemper C, Kunkel D, Tröger H, Maul J, Moos V, Berg E, Ullrich R, Schulzke JD, Stein H, Duchmann R, Zeitz M, Schneider T
Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART.
Blood 2006; 108(9):3072-8.
Rieger K, Loddenkemper C, Maul J, Fietz T, Wolff D, Terpe H, Steiner B, Berg E, Miehlke S, Bornhäuser M, Schneider T, Zeitz M, Stein H, Thiel E, Duchmann R, Uharek L
Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD.
Blood 2006; 107(4):1717-23.


Bitte wenden Sie sich an Frau
Birgit Röders
t: +49 30 8445 2820